NO932148L - Fusjonspolypeptider - Google Patents
FusjonspolypeptiderInfo
- Publication number
- NO932148L NO932148L NO93932148A NO932148A NO932148L NO 932148 L NO932148 L NO 932148L NO 93932148 A NO93932148 A NO 93932148A NO 932148 A NO932148 A NO 932148A NO 932148 L NO932148 L NO 932148L
- Authority
- NO
- Norway
- Prior art keywords
- dpp
- fusion polypeptides
- fusion protein
- extension
- proteins
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 230000004927 fusion Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 108010067722 Dipeptidyl Peptidase 4 Proteins 0.000 abstract 2
- 102100025012 Dipeptidyl peptidase 4 Human genes 0.000 abstract 2
- 102000037865 fusion proteins Human genes 0.000 abstract 2
- 108020001507 fusion proteins Proteins 0.000 abstract 2
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 102000034288 naturally occurring fusion proteins Human genes 0.000 abstract 1
- 108091006048 naturally occurring fusion proteins Proteins 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57536—Endothelin, vasoactive intestinal contractor [VIC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/50—Fusion polypeptide containing protease site
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Vascular Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62672790A | 1990-12-13 | 1990-12-13 | |
PCT/US1991/009152 WO1992010576A1 (en) | 1990-12-13 | 1991-12-12 | Fusion polypeptides |
Publications (2)
Publication Number | Publication Date |
---|---|
NO932148D0 NO932148D0 (no) | 1993-06-11 |
NO932148L true NO932148L (no) | 1993-08-09 |
Family
ID=24511577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93932148A NO932148L (no) | 1990-12-13 | 1993-06-11 | Fusjonspolypeptider |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0561971A1 (ja) |
JP (1) | JPH06503473A (ja) |
AU (1) | AU662508B2 (ja) |
CA (1) | CA2094512A1 (ja) |
CZ (1) | CZ109393A3 (ja) |
FI (1) | FI932680A0 (ja) |
HU (1) | HUT69963A (ja) |
IE (1) | IE914347A1 (ja) |
NO (1) | NO932148L (ja) |
RU (1) | RU2114119C1 (ja) |
SK (1) | SK60893A3 (ja) |
TW (1) | TW213923B (ja) |
WO (1) | WO1992010576A1 (ja) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050272652A1 (en) | 1999-03-29 | 2005-12-08 | Gault Victor A | Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity |
US6759393B1 (en) | 1999-04-12 | 2004-07-06 | Pfizer Inc. | Growth hormone and growth hormone releasing hormone compositions |
CA2303702A1 (en) * | 1999-04-12 | 2000-10-12 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
JP2003514532A (ja) * | 1999-11-19 | 2003-04-22 | トランスカーヨティック セラピーズ インコーポレイテッド | 生成物の産生量を最適化するための核酸構築体 |
EP1205551A1 (en) * | 2000-11-09 | 2002-05-15 | Pfizer Products Inc. | Growth hormone and growth hormone releasing hormone compositions |
JP4865565B2 (ja) | 2003-12-09 | 2012-02-01 | ノヴォ ノルディスク アー/エス | Glp−1アゴニストを用いた食物選択の制御 |
EP2316446A1 (en) | 2004-06-11 | 2011-05-04 | Novo Nordisk A/S | Counteracting drug-induced obesity using GLP-1 agonists |
US8263545B2 (en) | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
WO2006086769A2 (en) | 2005-02-11 | 2006-08-17 | Amylin Pharmaceuticals, Inc. | Gip analog and hybrid polypeptides with selectable properties |
US7855279B2 (en) | 2005-09-27 | 2010-12-21 | Amunix Operating, Inc. | Unstructured recombinant polymers and uses thereof |
EP1996220B2 (en) † | 2006-03-06 | 2023-08-16 | Amunix Operating Inc. | Unstructured recombinant polymers and uses thereof |
US8497240B2 (en) | 2006-08-17 | 2013-07-30 | Amylin Pharmaceuticals, Llc | DPP-IV resistant GIP hybrid polypeptides with selectable properties |
DK2393828T3 (en) | 2009-02-03 | 2017-01-23 | Amunix Operating Inc | Extended recombinant polypeptides and compositions comprising same |
US20120263701A1 (en) | 2009-08-24 | 2012-10-18 | Volker Schellenberger | Coagulation factor vii compositions and methods of making and using same |
EP2573103B1 (en) * | 2010-01-29 | 2017-07-05 | Archer-Daniels-Midland Company | Peptide domains that bind small molecules of industrial significance |
US10370430B2 (en) | 2012-02-15 | 2019-08-06 | Bioverativ Therapeutics Inc. | Recombinant factor VIII proteins |
SG11201404885RA (en) | 2012-02-15 | 2014-09-26 | Amunix Operating Inc | Factor viii compositions and methods of making and using same |
US10548953B2 (en) | 2013-08-14 | 2020-02-04 | Bioverativ Therapeutics Inc. | Factor VIII-XTEN fusions and uses thereof |
AU2016301303B2 (en) | 2015-08-03 | 2021-10-07 | Bioverativ Therapeutics Inc. | Factor IX fusion proteins and methods of making and using same |
CN111051338A (zh) * | 2017-06-29 | 2020-04-21 | 乌雷卡有限公司 | 具有改进的药物学性能的前药肽 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4703004A (en) * | 1984-01-24 | 1987-10-27 | Immunex Corporation | Synthesis of protein with an identification peptide |
US4569794A (en) * | 1984-12-05 | 1986-02-11 | Eli Lilly And Company | Process for purifying proteins and compounds useful in such process |
CA1340522C (en) * | 1987-03-10 | 1999-05-04 | Heinz Dobeli | Fusion proteins containing neighbouring histidines for improved purification |
DE69014115T2 (de) * | 1989-06-16 | 1995-05-24 | Upjohn Co | Stabilisierte, starke grf-analoga. |
DK0527778T3 (da) * | 1990-04-09 | 1996-10-21 | Upjohn Co | Forbedret fremgangsmåde til rensning af rekombinante proteiner og forbindelser, som er anvendelige ved en sådan fremgangsmåde |
-
1991
- 1991-12-12 AU AU91165/91A patent/AU662508B2/en not_active Ceased
- 1991-12-12 RU RU93045577A patent/RU2114119C1/ru active
- 1991-12-12 CA CA002094512A patent/CA2094512A1/en not_active Abandoned
- 1991-12-12 EP EP92901817A patent/EP0561971A1/en not_active Withdrawn
- 1991-12-12 HU HU9301705A patent/HUT69963A/hu unknown
- 1991-12-12 WO PCT/US1991/009152 patent/WO1992010576A1/en not_active Application Discontinuation
- 1991-12-12 JP JP4501996A patent/JPH06503473A/ja active Pending
- 1991-12-12 CZ CS931093A patent/CZ109393A3/cs unknown
- 1991-12-12 SK SK60893A patent/SK60893A3/sk unknown
- 1991-12-13 IE IE434791A patent/IE914347A1/en not_active Application Discontinuation
- 1991-12-17 TW TW080109839A patent/TW213923B/zh active
-
1993
- 1993-06-11 NO NO93932148A patent/NO932148L/no unknown
- 1993-06-11 FI FI932680A patent/FI932680A0/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI932680A (fi) | 1993-06-11 |
IE914347A1 (en) | 1992-06-17 |
HUT69963A (en) | 1995-09-28 |
NO932148D0 (no) | 1993-06-11 |
FI932680A0 (fi) | 1993-06-11 |
SK60893A3 (en) | 1993-10-06 |
CZ109393A3 (en) | 1994-01-19 |
RU2114119C1 (ru) | 1998-06-27 |
CA2094512A1 (en) | 1992-06-14 |
JPH06503473A (ja) | 1994-04-21 |
HU9301705D0 (en) | 1993-10-28 |
TW213923B (ja) | 1993-10-01 |
WO1992010576A1 (en) | 1992-06-25 |
AU662508B2 (en) | 1995-09-07 |
EP0561971A1 (en) | 1993-09-29 |
AU9116591A (en) | 1992-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO932148L (no) | Fusjonspolypeptider | |
Bedarkar et al. | Relaxin has conformational homology with insulin | |
Matsuo et al. | Synthesis of the porcine LH-and FSH-releasing hormone by the solid-phase method | |
CA1223198A (en) | Repair of tissue in animals | |
BG60256B1 (bg) | Рекомбинантен метод за получаване на лимфотоксин | |
RU93045577A (ru) | Слитные полипептиды | |
NZ504752A (en) | Hydrophobically-modified protein compositions (particularly hedgehog proteins) | |
JPS6410999A (en) | Production of physiologically active peptide containing cysteine residue | |
DK149092C (da) | Analogifremgangsmaade til fremstilling af tripeptider eller farmaceutisk acceptable syreadditionssalte deraf | |
CN102757974A (zh) | 一种重组人表皮生长因子的新型制备方法 | |
JPS6420095A (en) | Polypeptide having anti-blood coagulating action | |
DK162130B (da) | Grf-analoge peptider, fremgangsmaade til fremstilling deraf, grf-analoge peptider som terapeutiske midler, anvendelse af grf-analoge peptider, fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende grf-analoge peptider samt parenterale farmaceutiske praeparater indeholdende grf-analoge peptider | |
Burke et al. | Superactive insulins | |
Low et al. | Solid-phase synthesis of thymosin. beta. 4: chemical and biological characterization of the synthetic peptide | |
FR2408580A1 (fr) | Compositions de polypeptides contenant la sequence l-arginine-l-lysine-(acide l-aspartique)-l-valine-l-tyrosine, leur procede d'obtention et compositions therapeutiques en comportant | |
Lai et al. | Primary structure of cholera toxin B-subunit | |
FR2408581A1 (fr) | Composition de pentapeptide, son procede d'obtention et composition therapeutique en comportant | |
KR890014735A (ko) | 변형 단백질 | |
AU6393990A (en) | Hiv related peptides | |
Massey et al. | Guinea pig proinsulin. Primary structure of the C-peptide isolated from pancreas | |
YAMASHIRO et al. | β‐Endorphin: Synthesis and properties of double‐headed and related analogs | |
US4330465A (en) | Novel β-endorphin analogs | |
KNORR et al. | [B22-D-Arginine] Insulin: synthesis and biological properties | |
Kubota et al. | BIOCHEMICAL STUDIES ON HUMAN SALIVARY PROTEINS II. PRELIMINARY CHARACTERIZATION OF A FRACTION WITH HYPOCALCEMIC AND LEUKOCYTOSIS-PROMOTING ACTIVITIES IN THE DIGEST OF SALIVA-PAROTIN-A BY PRONASE P | |
Shields et al. | Expression of Preprosomatostatin Genes in Heterologous Cells |